(Q35623339)

9 August 2017

1 reference

title

Mucosal immunization against respiratory bacterial pathogens (English)

1 reference

9 August 2017

0 references

A Ruth Foxwell

1

1 reference

9 August 2017

Jennelle M Kyd

series ordinal

2

1 reference

9 August 2017

Allan W Cripps

series ordinal

3

1 reference

9 August 2017

publication date

1 August 2003

1 reference

Expert Review of Vaccines

9 August 2017

published in

1 reference

9 August 2017

volume

2

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

551-560

1 reference

Clinical and economic implications of antimicrobial resistance for the management of community-acquired respiratory tract infections

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Molecular mechanisms regulating persistent Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Examining unmet needs in infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Costs of chronic bronchitis and COPD: a 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Cost-effectiveness considerations in otitis media treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Bacterial eradication in the treatment of otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

The burden of pneumococcal disease: the role of conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Tuberculosis: latency and reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Molecular characterization of Corynebacterium diphtheriae isolates, Russia, 1957-1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Pertussis of adults and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Reduction in the Incidence of Acute Bronchitis by an OralHaemophilus influenzaeVaccine in Patients with Chronic Bronchitis in the Highlands of Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Recent advances in mucosal vaccines and adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Strategies of immunization against mucosal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Antigen sampling across epithelial barriers and induction of mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Medicinal chemistry and therapeutic potential of CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Bacterial ghosts: non-living candidate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.551

21 January 2018

Identifiers

DOI

10.1586/14760584.2.4.551

1 reference

9 August 2017

1 reference